Increased serum levels of pigment epithelium-derived factor (PEDF), a marker of insulin resistance, and the non-use of aspirin at baseline could “predict” the favorable response of the left main TBRmax (reduction from 2.17 to 1.93 (−12%), p = 0.014) to add-on therapy. Here, SERPINF1 is linked to Insulin resistance.